CYTOKINES AND ANTICYTOKINES IN THE PATHOGENESIS OF SEPSIS-Reference-Cited by-同舟云学术

CYTOKINES AND ANTICYTOKINES IN THE PATHOGENESIS OF SEPSIS

Published:1999-06 Issue:2 Volume:13 Page:413-426
ISSN:0891-5520
Container-title:Infectious Disease Clinics of North America
language:en
Short-container-title:Infectious Disease Clinics of North America

Author:

van der Poll Tom,van Deventer Sander J.H.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference56 articles.

1. Differential sensitivity to Escherichia coli infection in mice lacking tumor necrosis factor p55 or interleukin-1 p80 receptors;Acton;Arch Surg,1996

2. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells and in mice;Aderka;J Immunol,1989

3. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors;Aderka;J Exp Med,1992

4. The tumor necrosis factor ligand and receptor families;Bazzoni;N Engl J Med,1996

5. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance;Berg;J Clin Invest,1995

Cited by 271 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a nomogram to predict risk of septic cardiomyopathy in the intensive care unit;Scientific Reports;2024-06-19

2. Determining the Association Between the Origin of Sepsis and the Severity of Sepsis in Intensive Care Unit (ICU) Patients Using Acute Physiology and Chronic Health Evaluation (APACHE) IV;Cureus;2024-02-21

3. Ameliorative effect of anisodamine (654-1/654-2) against myocardial dysfunction induced by septic shock via the NF-κB/NLRP-3 or the PI3K-AKT/NF-κB pathway;Phytomedicine;2024-01

4. The Mechanisms of Action of Hyperbaric Oxygen in Restoring Host Homeostasis during Sepsis;Biomolecules;2023-08-07

5. IL-10 in combination with IL-12 and TNF-α attenuates CXCL8/CXCR1 axis in peritoneal macrophages of mice infected with Staphylococcus aureus through the TNFR1-IL-1R-NF-κB pathway;International Immunopharmacology;2023-07